3 Charts: Medicare Drug Price Negotiations January 31, 2024 News Release Under the Inflation Reduction Act, the federal government for the first time will negotiate directly with drug companies to determine the prices that Medicare will pay for certain high expenditure drugs covered under Medicare Part D (starting in 2026) and Part B (starting in 2028). Part D covers retail prescription…
FAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program January 31, 2024 Issue Brief The Centers for Medicare & Medicaid Services (CMS) recently issued initial guidance describing CMS’s plans for implementation of the new Medicare Drug Price Negotiation Program, which was established by the Inflation Reduction Act. These FAQs address several questions related to Medicare’s drug price negotiation program and how CMS intends to implement the new program, with a focus on the details that apply for 2026, the first year that negotiated prices will be available under this new program.
Distribution of Mental Health Treatment Facilities, By Ownership Type January 31, 2024 State Indicator
Distribution of Substance Use Treatment Facilities, By Ownership Type January 31, 2024 State Indicator
Percent of Mental Health Treatment Facilities Reporting Participation with Insurers January 31, 2024 State Indicator
Percent of Substance Use Treatment Facilities Reporting Participation with Insurers January 31, 2024 State Indicator
Count and Rate per 100,000 of Mental Health Treatment Facility Beds, By Type January 31, 2024 State Indicator
Count and Rate per 100,000 of Substance Use Treatment Facility Beds, By Type January 31, 2024 State Indicator